PPT-Dolutegravir vs. Raltegravir
SPRING2 Study Dolutegravir versus Raltegravir SPRING2 Design Source Raffi F et al Lancet 201338173543 Dolutegravir 50 mg QD Fixeddose NRTI backbone n 411 Raltegravir
Download Presentation
"Dolutegravir vs. Raltegravir" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.